LEVLEN

DEAD

Serial Number

73560226

Owner

BAYER HEALTHCARE PHARMACEUTICALS INC.

Attorney

William F. Lawrence, Esq.

First Use Date

Sep 13, 1985

Filing Date

Sep 26, 1985

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LEVLEN Trademark

Serial Number: 73560226 • Registration: 1440995

LEVLEN is a trademark filed by BAYER HEALTHCARE PHARMACEUTICALS INC. on September 26, 1985. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

BAYER HEALTHCARE PHARMACEUTICALS INC. (19 trademarks)

100 BAYER ROAD
PITTSBURGH, PA 15205

Entity Type: 03

BERLEX LABORATORIES, INC. (73 trademarks)

WAYNE, NJ 07470

Entity Type: 03

Legal Representation

Attorney of Record

William F. Lawrence, Esq.

234 trademarks filed View all →

Correspondence Address

William F. Lawrence, Esq. Frommer Lawrence & Haug LLP

745 Fifth Avenue

NEW YORK

NY 10151

UNITED STATES

Trademark Details

Filing Date

September 26, 1985

Registration Date

June 2, 1987

First Use Anywhere

September 13, 1985

First Use in Commerce

September 13, 1985

Published for Opposition

March 10, 1987

Cancellation Date

March 27, 2020

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Mar 27, 2020 CAEX

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Mar 27, 2020 CAEX

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jun 2, 2016 REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jun 2, 2016 REM2

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jan 29, 2014 ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jan 29, 2014 ASGN

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Sep 16, 2008 RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Sep 16, 2008 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Sep 16, 2008 89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Sep 16, 2008 89AG

RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 9

Aug 1, 2008 PR89

RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 9

Aug 1, 2008 PR89

PAPER RECEIVED

Aug 1, 2008 MAIL

PAPER RECEIVED

Aug 1, 2008 MAIL

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

Feb 1, 2008 PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

Feb 1, 2008 PR89

ASSIGNED TO PARALEGAL

Feb 1, 2008 PLGL

ASSIGNED TO PARALEGAL

Feb 1, 2008 PLGL

TEAS SECTION 8 & 9 RECEIVED

Nov 28, 2007 E89R

TEAS SECTION 8 & 9 RECEIVED

Nov 28, 2007 E89R

CASE FILE IN TICRS

Oct 30, 2006 CFIT

CASE FILE IN TICRS

Oct 30, 2006 CFIT

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Oct 31, 1992 C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Oct 31, 1992 C15A

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Aug 14, 1992 815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Aug 14, 1992 815F

REGISTERED-PRINCIPAL REGISTER

Jun 2, 1987 R.PR

REGISTERED-PRINCIPAL REGISTER

Jun 2, 1987 R.PR

PUBLISHED FOR OPPOSITION

Mar 10, 1987 PUBO

PUBLISHED FOR OPPOSITION

Mar 10, 1987 PUBO

NOTICE OF PUBLICATION

Feb 9, 1987 NPUB

NOTICE OF PUBLICATION

Feb 9, 1987 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 13, 1987 CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 13, 1987 CNSA

REINSTATED

Dec 15, 1986 REIN

REINSTATED

Dec 15, 1986 REIN

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 14, 1986 CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 14, 1986 CRFA

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jun 18, 1986 ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jun 18, 1986 ABN2

NON-FINAL ACTION MAILED

Dec 12, 1985 CNRT

NON-FINAL ACTION MAILED

Dec 12, 1985 CNRT

ASSIGNED TO EXAMINER

Dec 9, 1985 DOCK

ASSIGNED TO EXAMINER

Dec 9, 1985 DOCK

Related Trademarks

More from this Owner

DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE

DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT

More in Same Class

ILLOXAN

MEDICAP PHARMACY